Autopsy report · NCT00621036

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

“MyVax did not meet its primary endpoints”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of Texas Southwestern Medical Center

Sponsor type

University, hospital or other

Conditions

Brain and Central Nervous System Tumors; Lymphoma; Lymphoproliferative Disorder; Small Intestine Cancer

Interventions

autologous immunoglobulin idiotype-KLH conjugate vaccine; sargramostim; methotrexate; thiotepa; radiation therapy

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma
  “Primary Endpoint not met” (58% match in meaning)
• Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer
  “primary endpoint was not met” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.